Minor salivary gland biopsy: its importance in rheumatoid arthritis and secondary Sjögren's síndrome

  • María Florencia Rodriguez General Hospital of Acute Bernardino Rivadavia, Autonomous City of Buenos Aires, Argentina
  • Cristian Troitiño General Hospital of Acute Bernardino Rivadavia, Autonomous City of Buenos Aires, Argentina
  • Felix Enrique Romanini General Hospital of Acute Bernardino Rivadavia, Autonomous City of Buenos Aires, Argentina
  • Anastasia Secco General Hospital of Acute Bernardino Rivadavia, Autonomous City of Buenos Aires, Argentina
Keywords: secondary Sjögren’s Syndrome, minor salivary gland biopsy, lymphocyte sialoadenitis, Rheumatoid Arthritis

Abstract

Secondary Sjögren’s Syndrome (SSs) is common in patients with Rheumatoid Arthritis (RA). Objectives: to determine if lymphocytic sialoadenifitis (FLS) is associated with clinical and serological differences in a group of patients with RA and SSs. Methods: patients with a diagnosis of RA and SSs were included, which of them presented FLS in the salivary gland biopsy, clinical and serological characteristics were compared. Results: 88 patients were included, 92% women, mean age of 53 years (SD ± 11.3) and 12.5 years of evolution of RA (RIC 6-7). 63.6% had SLF versus 36.4% who did not. In the univariate analysis, a statistically significant association was found between FLS + and the variables: parotidomegaly, interstitial lung disease, hypergammaglobulinemia, hypocomplementemia, rheumatoid factor, positive ANF, and extra-articular and/ or extraglandular manifestations. In the multivariate analysis, the variables independently associated with the presence of FLS were: extra-articular and/or extraglandular manifestations (OR 5.67, 95% CI 1.6-20), positive ANF (OR 11.7, 95% CI 1.6-83) and hypergammaglobulinemia (OR 21, 95% CI 2.46-179). Conclusion: patients with RA and SSs with FLS have a higher frequency of extra-articular and extraglandular manifestations and serological differences, which would imply a different clinical follow-up.

References

I. Aletaha D, Neogi T, Silman AJ. Rheumatoid arthritis classification criteria: an American College of Rheumatology/ European League Against Rheumatism collaborative initiative. Arthritis Rheum. 2010;62:2569-81.

II. Vitali C, Bombardieri S, Jonsson R, et al. Classification criteria for Sjogren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum. 2002 Dis 61, 554–8.

III. Ramos-Casals M, Brito-Zeron P, Font J. The overlap of Sjogren’s syndrome with other systemic autoinmune diseases. Arthritis Rheum 2007;36:246-55.

IV. Theander E, Jacobsson LT. Relationship of Sjogren’s syndrome to other connective tissue and autoinmune disorders. Rheum Dis Clin North Am 2008;34:935-47,VIII-IX.

V. Chisholm y Mason. Labial salivary gland biopsy in Sjogren’s disease. J. clin. Path. 1968;21:656-660.

VI. Rosas Gomez de Salazar J, Miguel Senabre Gallego J, Santos Ramırez C. Manejo de las manifestaciones extraglandulares del síndrome de Sjögren primario. Reumatol Clin. 2010; 6(S2):6–11.

VII. Ramos-Casals M, García-Carrasco M, Gil G y Claver G. El síndrome de Sjögren. Enfermedades sistémicas autoinmunes (II). JANO 17-23 octubre 2003. Vol. LXV Nº 1.492.

VIII. Shiboski C, Shiboski S, Seror R, Criswell L, Labetoulle M, Lietman T, Rasmussen A, Scofield H, Vitali C, Bowman S, Mariette X. 2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjögren’s síndrome. Ann Rheum Dis 2017;76:9–16.

IX. Fragoulis G, Fragkioudaki S, Reilly J, Kerr S, McInnes I, Moutsopoulos H. Analysis of the cell populations composing the mononuclear cell infiltrates in the labial minor salivary glands from patients with rheumatoid arthritis and sicca síndrome. Journal of Autoimmunity 2016 1-7.

Published
2019-09-01
How to Cite
1.
Rodriguez MF, Troitiño C, Romanini FE, Secco A. Minor salivary gland biopsy: its importance in rheumatoid arthritis and secondary Sjögren’s síndrome. Rev. Argent. Reumatol. [Internet]. 2019Sep.1 [cited 2024May11];30(3):15 -18. Available from: https://ojs.reumatologia.org.ar/index.php/revistaSAR/article/view/442
Section
Original Article